Chester County News and Community Website
NEWTOWN, PA — In a market landscape dominated by titans in the biotech and healthcare technology sectors, Helius Medical Technologies, Inc. (Nasdaq: HSDT) found themselves in a David versus Goliath …
Helius Medical Technologies: Strides Towards Reimbursement for Innovative PoNS Therapy Amidst Financial Challenges Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has recently shared its financial results for the full year of 2023, accompanying these figures with a business update for …
Orchestra BioMed: Continuing the Momentum into a Promising Future Read More
PHILADELPHIA, PA — A paramount scientific breakthrough has been achieved by the combined intellectual prowess of researchers from the University of Pennsylvania (Penn), J. Craig Venter Institute (JCVI), and the …
Constructing the Path to Brave New Biotech: Single-copy Human Artificial Chromosomes Read More
WEST CHESTER, PA — Pathways Neuro Pharma, Inc., a Chester County-based biotechnology firm, has secured a U.S. patent for its groundbreaking neuroreceptor technology.
Pathways Neuro Pharma Clinches U.S. Patent for Pioneering Neuroreceptor Technology Read More
WILMINGTON, DE — In a trailblazing partnership, Carolina Biological Supply Company, a leading supplier of school science materials, and the ChristianaCare Gene Editing Institute, have combined forces to demystify a …
Delaware Schools Empower Next-Generation Scientists with CRISPR in a Box Read More
HATBORO, PA — Azzur Group has announced the launch of analytical laboratory testing services for advanced therapeutic medicinal products (ATMPs). This new offering comes at a time when more than …
Azzur Group Bolsters Biotech with Advanced Therapies Testing Services Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a pioneer in the biotechnology field, is set to hold an in-person Clinical Showcase on February 21, 2024, at the Nasdaq Market Site …
Ocugen to Spotlight Promising Gene Therapy in Clinical Showcase Read More
KING OF PRUSSIA, PA — Global biotech leaders CSL and Arcturus Therapeutics have released the results of a six-month follow-up analysis comparing their self-amplifying messenger RNA (sa-mRNA) COVID-19 vaccine, ARCT-154, …
CSL’s ARCT-154 Vaccine Outperforms Comirnaty in Six-Month COVID-19 Study Read More
WAYNE, PA — Neuraptive Therapeutics, Inc., a Pennsylvania-based biotech company, recently announced a major breakthrough in the treatment of peripheral nerve injuries. The firm’s successful demonstration of proof-of-concept in the …
Neuraptive Therapeutics’ Groundbreaking Study Paves Way for Improved Peripheral Nerve Injury Treatment Read More
PLYMOUTH MEETING, PA — A groundbreaking study published in the December 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network, has shed light on the efficacy of immunotherapy in …
Immunotherapy Shows Similar Efficacy Across Racial and Ethnic Lines in NSCLC, New Study Reveals Read More